Asked by: Giles Watling (Conservative - Clacton)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that the NHS cancer dashboard offers disaggregated data on (a) liver, (b) brain, (c) oesophageal, (d) pancreatic and (e) stomach cancer.
Answered by Steve Brine
Public Health England (PHE) and NHS England developed the first iteration of the cancer dashboard in response to recommendations in the Independent Cancer Taskforce report ‘Achieving world-class cancer outcomes: a strategy for England 2015-2020’. This includes data on breast, colorectal, lung and prostate cancers. Further cancer sites were not included because of the risk of making patients identifiable when viewing data for individual hospitals or clinical commissioning groups
PHE is working with NHS England’s Cancer Strategy Team on the next phase of the dashboard development. The types of cancer to be included on the cancer dashboard will be informed by the needs of key stakeholders including cancer charities.
Asked by: Giles Watling (Conservative - Clacton)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how the risks of mobile applications are assessed by NHS Digital for inclusion in the NHS Apps Library.
Answered by Matt Hancock
Mobile applications are assessed initially via a clinical review within NHS England to establish whether the app fits with National Health Service values and can evidence benefit to the users of the app. Following this, apps are taken through a comprehensive assessment which takes into account relevant regulation, legislation, national standards and best practice to ensure that developers of apps understand their obligations and can evidence that their products conform with these.
Asked by: Giles Watling (Conservative - Clacton)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to prevent illicit drugs being brought into secure mental health wards.
Answered by Jackie Doyle-Price
Operating safe, therapeutic and clinically effective services is the responsibility of service providers to manage in accordance with best practice. NHS England’s national service specifications for adult medium and low secure mental health services reinforce the importance of procedural, physical and relational security to address such matters. For high secure services, the Secretary of State for Health and Social Care issues specific Directions to providers regarding the way they must manage their security arrangements. These arrangements cover illicit substances.